BioSpace News Archive

Business

Vectura Group plc: Interim Results For The Six Months Ended 30 June 2018

Vectura regaining momentum with continued inhaled revenue and adjusted EBITDA growth

September 12, 2018
·
6 min read
Medigene AG: Medigene participates at further conferences in September 2018

Medigene AG today announced its participation at the following upcoming investor and scientific conferences:

September 12, 2018
·
1 min read
Driving real-time productivity insights with connected laboratory automation

Tecan is offering its customers unprecedented insight into how their Fluent® and Freedom EVO® liquid handing platforms are being used, thanks to its Introspect™ and Common Notification System (Tecan CNS™) software tools.

September 12, 2018
·
3 min read
Biopharma Company Arecor raises £6m for revolutionary diabetes treatments

Arecor has raised £6 million from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes.

September 12, 2018
·
8 min read
Business

Oncolytics Biotech® Announces a Master Clinical Supply Agreement of an Anti-PD-L1 Checkpoint Inhibitor for use in the Company’s Clinical Program

Oncolytics Biotech® Inc. today announced that it has entered into a Master Clinical Supply Agreement (Agreement) with F. Hoffmann-La Roche Ltd (Roche) to supply atezolizumab (Tecentriq®) for use in the company’s clinical development program.

September 12, 2018
·
3 min read
Deals

MorphoSys AG to be listed in MDAX

MorphoSys AG announced today that its shares will be included in the MDAX as of September 24, 2018 as announced by Deutsche Börse.

September 12, 2018
·
4 min read
Novo Holdings invests CHF 6.8 Million in Polyphor to accelerate the development of novel antibiotics against multi-drug resistant Gram-negative pathogens

Novo REPAIR Impact Fund to invest up to CHF 11.5M in Polyphor’s antibiotic OMPTA pipeline through a CHF 6.8M equity investment, as well as a potential additional CHF 4.7M investment against program-specific royalties

September 12, 2018
·
4 min read
Clinithink receives RARE Champion of Hope award for their ‘notable efforts’ in rare disease

Clinithink has been selected to receive the RARE Champion of Hope – Collaborations in Science and Technology award at the 7th Annual RARE Patient Advocacy Summit on October 4th in Irvine, California.

September 12, 2018
·
2 min read
Business

DANFORTH ADVISORS NAMES ROBERT DICKEY IV MANAGING DIRECTOR, MID ATLANTIC REGION

Danforth Advisors, LLC today announced additional regional leadership and support with the appointment of Robert Dickey IV as Managing Director, Mid Atlantic Region.

September 12, 2018
·
2 min read
Business

Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer

Crescendo Biologics Ltd today announces that Pavel Pisa, MD, PhD, has been appointed as Chief Medical Officer of the Company with immediate effect.

September 12, 2018
·
3 min read